018680 — Seoul Pharma Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual balance sheet for Seoul Pharma Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	ARS	ARS	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	15,061	13,820	11,728	9,664	7,540
Net Total Accounts Receivable
Net Total Receivables	3,238	4,489	5,040	5,131	9,465
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	25,933	24,814	26,012	25,609	32,257
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	35,476	34,055	30,676	31,330	33,855
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	65,087	62,250	62,428	63,305	71,620
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	18,447	28,805	13,891	20,532	14,141
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	36,235	43,292	27,006	24,741	31,448
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	28,852	18,958	35,422	38,564	40,172
Total Liabilities & Shareholders' Equity	65,087	62,250	62,428	63,305	71,620
Total Common Shares Outstanding